Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gittelman

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Urology|May 9, 2001
The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancerK Tomera, D Gleason, M Gittelman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2020
T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell TransplantationMark Leick, Rachel M Gittelman, Erik Yusko, et al.
Genome Research|June 25, 2015
Comprehensive identification and analysis of human accelerated regulatory DNARachel M Gittelman, Enna Hun, Ferhat Ay, et al.
International Journal of Epidemiology|December 1, 1990
The effective case management of childhood diarrhoea with oral rehydration therapy in the Kingdom of LesothoD L Hatch, R C Vreuls, M J Toole, et al.
American Journal of Physical Anthropology|October 14, 2011
Genetic ancestry and indigenous heritage in a Native American descendant community in BermudaJill B Gaieski, Amanda C Owings, Miguel G Vilar, et al.
Urology|October 8, 1999
Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study GroupC G Roehrborn, P Boyle, D Bergner, et al.
Diabetologia|November 4, 2020
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetesBart Keymeulen, André van Maurik, Dave Inman, et al.
Cancer Immunology Research|August 30, 2017
Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell ApoptosisRajeev K Shrimali, Shamim Ahmad, Vivek Verma, et al.
European Urology|June 28, 2014
Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancerEvan Y Yu, Robert H Getzenberg, Christopher C Coss, et al.
Science (New York, N.Y.)|March 19, 2016
Excavating Neandertal and Denisovan DNA from the genomes of Melanesian individualsBenjamin Vernot, Serena Tucci, Janet Kelso, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Urology|May 9, 2001
The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancerK Tomera, D Gleason, M Gittelman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2020
T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell TransplantationMark Leick, Rachel M Gittelman, Erik Yusko, et al.
Genome Research|June 25, 2015
Comprehensive identification and analysis of human accelerated regulatory DNARachel M Gittelman, Enna Hun, Ferhat Ay, et al.
International Journal of Epidemiology|December 1, 1990
The effective case management of childhood diarrhoea with oral rehydration therapy in the Kingdom of LesothoD L Hatch, R C Vreuls, M J Toole, et al.
American Journal of Physical Anthropology|October 14, 2011
Genetic ancestry and indigenous heritage in a Native American descendant community in BermudaJill B Gaieski, Amanda C Owings, Miguel G Vilar, et al.
Urology|October 8, 1999
Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study GroupC G Roehrborn, P Boyle, D Bergner, et al.
Diabetologia|November 4, 2020
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetesBart Keymeulen, André van Maurik, Dave Inman, et al.
Cancer Immunology Research|August 30, 2017
Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell ApoptosisRajeev K Shrimali, Shamim Ahmad, Vivek Verma, et al.
European Urology|June 28, 2014
Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancerEvan Y Yu, Robert H Getzenberg, Christopher C Coss, et al.
Science (New York, N.Y.)|March 19, 2016
Excavating Neandertal and Denisovan DNA from the genomes of Melanesian individualsBenjamin Vernot, Serena Tucci, Janet Kelso, et al.
Pageof 6